10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8 | -27.3% | 195 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $11 | -26.7% | 195 | -25.3% | 0.00% | -25.0% |
| Q1 2023 | $15 | +87.5% | 261 | +15.5% | 0.00% | +100.0% |
| Q4 2022 | $8 | -99.8% | 226 | +34.5% | 0.00% | 0.0% |
| Q3 2022 | $5,000 | -37.5% | 168 | -2.3% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | -33.3% | 172 | +5.5% | 0.00% | -33.3% |
| Q1 2022 | $12,000 | -50.0% | 163 | +2.5% | 0.00% | -62.5% |
| Q4 2021 | $24,000 | 0.0% | 159 | -3.6% | 0.01% | -46.7% |
| Q3 2021 | $24,000 | -35.1% | 165 | -11.8% | 0.02% | -40.0% |
| Q2 2021 | $37,000 | +27.6% | 187 | +17.6% | 0.02% | +13.6% |
| Q1 2021 | $29,000 | – | 159 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |